Originally designed to empower patients, price transparency has transformed into a legal liability, becoming a documentation burden for healthcare institutions.
Read moreA COVID-19 vaccine received full FDA approval, prompting calls for vaccine mandates. But when patients act as consumers, regulatory approval...
Read morePhysician leaders call for advocacy, galvanizing the medical community to take up public health issues. But these calls appear hollow,...
Read morePolitical rhetoric on public health policy is now affecting individual patient decisions. Should politicians be held liable for the clinical...
Read moreCorporate medicine has changed the once autonomous physician profession into a traditional labor workforce, eliminating the art of medicine.
Read moreIndividualism has long defined America, but over the country's history, it has appeared differently - the current version being both...
Read moreTwo unique fields, each distinct on its own, yet inextricably linked through a set of words - rights and liberty...
Read moreNuance, a word often cited in discussions regarding the CDC opioid prescribing guidelines. But in citing nuance, they really mean...
Read moreThe CDC has defined the process through which it will revise the opioid prescribing guidelines. One that includes public commentary...
Read moreThe committee working with the committee revising the CDC opioid prescribing guidelines met in a public assembly, highlighting a contrast...
Read morePfizer recently announced the possibility of a third dose, a booster dose, for the COVID-19 vaccine. An announcement met with...
Read moreFreedom means many things to many people. Above all, the freedom to disagree. But when disagreements occur not just between...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy